[Hyperinflammatory immune response syndrome PIMS-TS]

Area of Science:

• Pediatric immunology
• Infectious disease epidemiology

Background:

• Pediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2 (PIMS-TS) is a rare hyperinflammatory condition.
• It typically manifests 2-6 weeks post-SARS-CoV-2 infection, primarily affecting schoolchildren.
• Common symptoms include fever, gastrointestinal issues, cardiovascular dysfunction, and neurological signs.

Purpose of the Study:

• To summarize the clinical presentation and management of PIMS-TS.
• To highlight the importance of early diagnosis and intervention.

Main Methods:

• Review of clinical signs and diagnostic criteria for PIMS-TS.
• Analysis of treatment protocols, including intensive care and methylprednisolone administration.

Main Results:

• PIMS-TS presents with diverse symptoms affecting multiple organ systems.
• Diagnostic criteria can vary among different authors.
• Intensive care with circulatory support and methylprednisolone is an effective treatment.

Conclusions:

• PIMS-TS requires prompt recognition and management.
• Effective treatment strategies contribute to favorable patient outcomes with low mortality and long-term consequences.